Survival impact of newly approved therapeutic agents in patients with advanced non-small cell lung cancer (NSCLC): A SEER-Medicare database analysis.
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7633-7633
◽
Keyword(s):
2017 ◽
Vol 143
(11)
◽
pp. 2375-2382
◽
Keyword(s):
2016 ◽
pp. 115-126
◽
Keyword(s):
2019 ◽
Vol 146
(1)
◽
pp. 67-74
◽
Keyword(s):
2020 ◽
Vol 108
(3)
◽
pp. e404-e405
Keyword(s):
2017 ◽
Vol 97
(1)
◽
pp. 128-137
◽